QTc prolongation after regadenoson administration

J Nucl Cardiol. 2012 Oct;19(5):1080-2. doi: 10.1007/s12350-012-9589-7.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adenosine A2 Receptor Agonists / adverse effects*
  • Aged
  • Electrocardiography / drug effects*
  • Humans
  • Male
  • Purines / adverse effects*
  • Pyrazoles / adverse effects*

Substances

  • Adenosine A2 Receptor Agonists
  • Purines
  • Pyrazoles
  • regadenoson